Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Antares Pharma (ATRS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart
Realtime quote and/or trade prices are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 285,139
  • Shares Outstanding, K 156,670
  • Annual Sales, $ 52,220 K
  • Annual Income, $ -24,340 K
  • 36-Month Beta 0.24
  • Price/Sales 5.52
  • Price/Cash Flow 0.00
  • Price/Book 8.00

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.58 +16.45%
on 11/08/17
2.30 -20.00%
on 10/23/17
-0.34 (-15.60%)
since 10/20/17
3-Month
1.58 +16.45%
on 11/08/17
4.09 -55.01%
on 10/09/17
-1.18 (-39.08%)
since 08/21/17
52-Week
1.58 +16.45%
on 11/08/17
4.09 -55.01%
on 10/09/17
-0.09 (-4.67%)
since 11/21/16

Most Recent Stories

More News
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Antares Pharma, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 22, 2017 - ATRS

NEW YORK, NY / ACCESSWIRE / November 20, 2017 / The following statement is being issued by Levi & Korsinsky, LLP:

ATRS : 1.85 (+1.65%)
SHAREHOLDER ALERT: Pomerantz Law Reminds Shareholders with Losses on their Investment in Antares Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline - ATRS

NEW YORK, NY / ACCESSWIRE / November 18, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against Antares Pharma, Inc. ("Antares" or the "Company") (NASDAQ: ATRS) and certain of...

ATRS : 1.85 (+1.65%)
The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Antares Pharma, Inc. Shareholders and a Lead Plaintiff Deadline of December 22, 2017

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Antares Pharma, Inc. (NASDAQ:ATRS) who purchased shares between December 21, 2016 ...

ATRS : 1.85 (+1.65%)
SHAREHOLDER ALERT: Pomerantz Law Reminds Shareholders with Losses on their Investment in Antares Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline - ATRS

NEW YORK, NY / ACCESSWIRE / November 16, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against Antares Pharma, Inc. ("Antares" or the "Company") (NASDAQ: ATRS) and certain of...

ATRS : 1.85 (+1.65%)
ATRS INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Antares Pharma, Inc. and a Lead Plaintiff Deadline of December 22, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased...

ATRS : 1.85 (+1.65%)
ANTARES LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Antares Pharma, Inc. To Contact The Firm

NEW YORK, NY / ACCESSWIRE / November 15, 2017 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Antares Pharma, Inc. ("Antares" or the "Company") (NASDAQ: ATRS) of the...

ATRS : 1.85 (+1.65%)
IMPORTANT ANTARES PHARMA, INC. INVESTOR REMINDER: Wolf Haldenstein Adler Freeman & Herz LLP Reminds Investors That a Securities Class Action Lawsuit Has Been Filed on Behalf of Investors Who Purchased Antares Pharma, Inc.

Lead Plaintiff Deadline is December 22, 2017

ATRS : 1.85 (+1.65%)
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Antares Pharma, Inc. (ATRS) & Lead Plaintiff Deadline - December 22, 2017

NEW YORK, NY / ACCESSWIRE / November 15, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Antares Pharma, Inc. ("Antares" or the "Company")...

ATRS : 1.85 (+1.65%)
SHAREHOLDER ALERT: Pomerantz Law Reminds Shareholders with Losses on their Investment in Antares Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline - ATRS

Pomerantz LLP announces that a class action lawsuit has been filed against Antares Pharma, Inc. ("Antares" or the "Company") (NASDAQ: ATRS) and certain of its officers. The class action, filed in United...

ATRS : 1.85 (+1.65%)
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Antares Pharma, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 22, 2017

The following statement is being issued by Levi & Korsinsky, LLP:

ATRS : 1.85 (+1.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Antares Pharma, Inc. develops, commercializes and markets novel delivery solutions, including needle-free and mini-needle injector systems, gel technologies and transdermal products, which improve both the efficiency of drug therapies and the quality of life for patients. The Company currently distributes...

See More

Key Turning Points

2nd Resistance Point 1.93
1st Resistance Point 1.87
Last Price 1.85
1st Support Level 1.78
2nd Support Level 1.75

See More

52-Week High 4.09
Fibonacci 61.8% 3.13
Fibonacci 50% 2.84
Fibonacci 38.2% 2.54
Last Price 1.85
52-Week Low 1.58

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart